Sika

European And US Mandates Will Spark Sustainable Construction Trends

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

07 Nov 24

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-30.0%

-0.3%

-30.0%

-0.3%

You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.

Author's Valuation

CHF 253.3236.9% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 2.72%

Shared on 23 Apr 25

Fair value Decreased 0.84%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Decreased 2.02%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 1.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 0.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 6.11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

CHF 253.32

36.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

3.27%

Chemicals revenue growth rate

0.61%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

4.66%

Calculation

CHF 1.63b

Earnings '28

28.48x

PE Ratio '28

CHF 46.45b

Market Cap '28

CHF 46.45b

Market Cap '28

160.52m

No. shares '28

CHF 289.37

Share Price '28

CHF 289.37 Share Price '28

Discounted to 2025 @ 4.65% p.a.

CHF 252.49

Fair Value '25